相关实验视频

Updated: Mar 8, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

乙胆测试的说明,禁忌和有用性

Fardeen Faiz¹, Shivani Mehta¹, Sierra Fleming¹

¹Georgia Heart Institute, Northeast Georgia Health System, Gainesville, GA, United States of America.

Cardiovascular revascularization medicine : including molecular interventions

|March 6, 2026

概括

乙胆 (ACh) 测试是诊断冠状动脉血管功能障碍的宝贵工具,用于患有非阻塞性冠状动脉 (ANOCA) 的心痛和患有非阻塞性冠状动脉 (MINOCA) 的心肌梗塞. 本次审查强调了其更新的协议,安全性和在这些疾病的精密医学中的作用.

科学领域:

心脏病学心脏病学
临床药理学临床药理学
诊断测试诊断测试诊断测试

背景情况:

非阻塞性冠状动脉 (ANOCA) 的心痛和非阻塞性冠状动脉 (MINOCA) 的心肌梗塞与冠状动脉血管功能障碍有关.
冠状动脉内乙胆 (ACh) 测试是诊断冠状动脉功能障碍的标准,但在协议标准化和安全性方面面临挑战.
现有的协议和安全数据需要当代更新以指导临床实践.

研究的目的:

审查ACH挑测试的指示,机制,协议,安全性和临床实用性.
将最近的多中心注册表数据和机械洞察纳入ACH测试实践.
为在ANOCA和MINOCA中使用ACH测试提供以实践为导向的指南.

主要方法:

对标准化ACH剂量策略 (注射剂和输液) 的审查以及与血液动力学评估的整合.
纳入来自DISCOVER-INOCA注册表和前性多中心内型研究的数据.
与爱尔贡诺文相比,ACh安全性的当代元分析以及基于2024年ESC指南的更新禁忌.

主要成果:

ACh测试显示了各种冠状动脉血管功能障碍内型的高诊断产量和定量差异化.
在ACH测试中出现重大并发症的发生率非常低 (<1%).
新出现的数据支持转向基于 ACh 测试结果的机制引导,内型特异性疗法.

结论:

通过北美注册和元分析验证的ACH测试,可以进行定量内型表型化.
在ANOCA和MINOCA中,ACh测试是诊断工具和精准医学平台.
以 ACh 测试为指导的量身定制治疗可以改善以患者为中心的结果.

关键词:

亚诺卡亚亚诺卡亚是什么意思乙烯基胆是一种冠状动脉的情况内皮质功能障碍内皮质功能障碍血管活性血管活性

更多相关视频

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

相关概念视频

Myasthenia Gravis: Diagnostic Tests

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...

Cholinergic Antagonists: Therapeutic Uses

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...